We are very pleased to introduce you to our new CEO, Diana Zelencova-Gopejenko, Ph.D.   Here, we find out a little bit more about Diana, including her medicinal chemistry expertise and how she plans to use her first-hand experience of the whole drug development cycle to both expand Molport’s current offering and introduce new, tailored MedChem tools to make sourcing diverse chemical compounds from around the world easier and faster.  By enhancing access to chemical compounds…